Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: Results of the French Adjuvant Study Group

Cancer

Volumn 104, Issue 2, 2005, Pages 240-250

  Benchalal, Mohamed ^a   Le Prisé, Elisabeth ^a   De Lafontan, Brigitte ^b   Berton Rigaud, Dominique ^c   Belkacemi, Yazid ^d   Romestaing, Pascale ^e   Peignaux, Karine ^f   Courdi, Adel ^g   Monnier, Alain ^h   Montcuquet, Philippe ⁱ   Goudier, Marie Josèphe ^j   Marchal, Christian ^k   Chollet, Philippe ^l   Abadie Lacourtoisie, Sophie ^m   Datchary, Jean ⁿ   Veyret, Corinne ^o   Kerbrat, Pierre ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e Centre Hospitalier Jules Courmont   (France)

^f Tum Inst Ctr Georges Francois L   (France)

^g CENTRE ANTOINE LACASSAGNE   (France)

^h Centre Hospitalier General Andre Boulloche   (France)

ⁱ Clinique Saint Vincent   (France)

^j Centre Hospitalier de Bretagne Sud   (France)

^k CENTRE ALEXIS VAUTRIN   (France)

^l CENTRE JEAN PERRIN   (France)

^m CENTRE PAUL PAPIN   (France)

ⁿ DUPUYTREN UNIVERSITY HOSPITAL   (France)

^o CENTRE HENRI BECQUEREL   (France)

more..

Author keywords

Adjuvant therapy; Breast carcinoma; Breast conserving surgery; Local recurrence; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN AGONIST; NAVELBINE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TIME; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; TAMOXIFEN; TIME FACTORS;

EID: 22244455720     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21161     Document Type: Article

References (52)

1. Fletcher GH. Implications of the density of clonogenic infestation in radiotherapy. Int J Radiat Oncol Biol Phys. 1986; 12:1675-1680.
2. Withers HR. Biologic basic for altered fractionation schemes. Cancer. 1985;55:2086-2095.
3. Mackillop WJ, Bates JH, O'Sullivan B, et al. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:243-250.
4. Champeme MH, Bieche I, Lizard S, et al. 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer. 1995;12:128-133.
5. Regitnig P, Moser R, Thalhammer M, et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol. 2002;198:190-197.
6. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:115-121.
7. Forrest AP, Steward HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet. 1996;348:708-713.
8. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 1996;88:1659-1664.
9. Liljegren G, Holmberg L, Adami HO, et al. Sector resection with or without postoperative radiotherapy for Stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst. 1994;86:717-722.
10. Recht A. Integration of systemic therapy and radiation therapy for patients with early-stage breast cancer treated with conservative surgery. Clin Breast Cancer. 2003;4:104-113.
11. Rutqvist LE, Rose C, Cavallin-Stahl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol. 2003;42:532-545.
12. Whelan TJ, Lada BM, Laukkanen E, et al. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group. Cancer Prev Control. 1997;1:228-240.
13. Fortin A, Larochelle M, Laverdiere J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17:101-109.
14. Whelan T, Clark R, Roberts R, et al. Ipsilateral breast tumor recurrence post-lumpectomy is predictive of subsequent mortality: results from a randomized trial. Int J Radiat Oncol Biol Phys. 1994;30:11-16.
15. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338:327-331.
16. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19-27.
17. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 1995;333:1444-1455.
18. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351:1451-1467.
19. Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996;334: 1356-1361.
20. Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21:555-563.
21. Benk V, Joseph L, Fortin P, et al. Effect of delay in initiating radiotherapy for patients with early stage breast cancer. Clin Oncol. 2004;16:6-11.
22. Nixon AJ, Recht A, Neuberg D, et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys. 1994;30:17-21.
23. Fourquet A, Dreyfus H, Colombani H, et al. Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer [abstract]. Int J Radiat Oncol Biol Phys. 1995;32(Suppl 1):260.
24. Whelan TJ, Clark RM, Levine MN, et al. The effect of delay in initiating radiotherapy post lumpectomy on local breast recurrence [abstract]. Int J Radiat Oncol Biol Phys. 1996: 36(Suppl 1):280.
25. Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1985;11: 137-145.
26. Slotman BJ, Meyer OW, Njo KH, et al. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 1994;30:206-212.
27. Vujovic O, Perera F, Dar AR, et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys. 1998;40:869-874.
28. Froud PJ, Mates D, Jackson JS, et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys. 2000;46:363-372.
29. Bucholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:23-35.
30. Fiets WE, van Helvoirt RP, Nortier JW, et al. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: a prospective, comparative, non-randomised study. Eur J Cancer. 2003;39:1081-1088.
31. Snedecor GW, Cochran WG. Statistical methods, 7th ed. Ames: Iowa State University Press, 1980.
32. Duncan DB. P-tests and intervals for comparison suggested by the data. Biometrics. 1975;31:339-359.
33. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1985;53:229-232.
34. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A. 1972;135:185-198.
35. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187-202.
36. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992;11: 19-25.
37. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;47:1233-1241.
38. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
39. Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14:1558-1564.
40. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of Stage I and II breast cancer. N Engl J Med. 1995;332:907-911.
41. Lee HD, Yoon DS, Koo JY, et al. Breast conserving therapy in Stage I and II breast cancer in Korea. Breast Cancer Res Treat. 1997;44:193-199.
42. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-1150.
43. Harris JR, Lippman ME, Morrow M, et al. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996.
44. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719-725.
45. Elkhuizen PH, Voogd AC, van den Broek LC, et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys. 1999;45:73-83.
46. Schnitt SJ, Connolly JL, Harris JR, et al. Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984;53:1049-1057.
47. Tavassoli FA. Pathology of the breast, 2nd ed. Stanford: Appleton Lange, 1998:37-56.
48. Locker AP, Ellis IO, Morgan DA, et al. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg. 1989;76:890-894.
49. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587-1591.
50. Bellon J, Come SE, Gelman R, et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial [abstract]. Int J Radiat Oncol Biol Phys. 2001;51(Suppl 1):4.
51. Wallgren A, Bernier J, Gelber RD, et al. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys. 1996;35:649-659.
52. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205-1210.